Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas-Mexico border.


Journal

Perspectives in public health
ISSN: 1757-9147
Titre abrégé: Perspect Public Health
Pays: United States
ID NLM: 101499631

Informations de publication

Date de publication:
Jul 2019
Historique:
pubmed: 18 8 2018
medline: 31 1 2020
entrez: 18 8 2018
Statut: ppublish

Résumé

The Rio Grande Valley (RGV) and Laredo regions located along the Texas-Mexico border consist of seven counties with a population of approximately 1.5 million people and a high uninsured rate (33.5%). Cervical cancer mortality in these border counties is approximately 30% higher than the rest of Texas. The RGV and Laredo areas were studied to better understand the state of access to cervical cancer prevention services along the Texas-Mexico border. Data on the population served and the services provided were analyzed to determine the gap between cervical cancer screenings recommended versus those received. Through interviews, we gathered the perspectives of 16 local stakeholders regarding cervical cancer screening for underserved individuals in the region. It is estimated that 69,139 uninsured women aged 21-64 years in the RGV/Laredo per year are recommended to undergo cervical cancer screening with Papanicolaou (Pap) and/or human papillomavirus (HPV) testing, but only 8941 (12.9%) Pap tests are being performed by the Federally Qualified Health Center (FQHC) serving uninsured women in these regions. Systemic barriers identified include insufficient provider clinical capacity, the high cost of healthcare, and uncertainty about government funding sources. Patient barriers identified include inadequate knowledge on navigating the local healthcare system, low health literacy, lack of money and childcare, an inability to miss work, limited transportation, and fear of deportation. Decreasing the disparity between cervical cancer screening services provided and those recommended requires addressing the barriers, identified by local experts, which prevent uninsured women from accessing care. These challenges are being addressed through ongoing programs and collaborations.

Sections du résumé

BACKGROUND BACKGROUND
The Rio Grande Valley (RGV) and Laredo regions located along the Texas-Mexico border consist of seven counties with a population of approximately 1.5 million people and a high uninsured rate (33.5%). Cervical cancer mortality in these border counties is approximately 30% higher than the rest of Texas. The RGV and Laredo areas were studied to better understand the state of access to cervical cancer prevention services along the Texas-Mexico border.
METHODS METHODS
Data on the population served and the services provided were analyzed to determine the gap between cervical cancer screenings recommended versus those received. Through interviews, we gathered the perspectives of 16 local stakeholders regarding cervical cancer screening for underserved individuals in the region.
FINDINGS RESULTS
It is estimated that 69,139 uninsured women aged 21-64 years in the RGV/Laredo per year are recommended to undergo cervical cancer screening with Papanicolaou (Pap) and/or human papillomavirus (HPV) testing, but only 8941 (12.9%) Pap tests are being performed by the Federally Qualified Health Center (FQHC) serving uninsured women in these regions. Systemic barriers identified include insufficient provider clinical capacity, the high cost of healthcare, and uncertainty about government funding sources. Patient barriers identified include inadequate knowledge on navigating the local healthcare system, low health literacy, lack of money and childcare, an inability to miss work, limited transportation, and fear of deportation.
CONCLUSION CONCLUSIONS
Decreasing the disparity between cervical cancer screening services provided and those recommended requires addressing the barriers, identified by local experts, which prevent uninsured women from accessing care. These challenges are being addressed through ongoing programs and collaborations.

Identifiants

pubmed: 30117782
doi: 10.1177/1757913918793443
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-205

Auteurs

K Boom (K)

Washington University in St. Louis, USA; The University of Texas MD Anderson Cancer Center, USA.

M Lopez (M)

The University of Texas MD Anderson Cancer Center, USA.

M Daheri (M)

Harris Health System, USA.

R Gowen (R)

Su Clínica, USA.

A Milbourne (A)

The University of Texas MD Anderson Cancer Center, USA.

P Toscano (P)

UTHealth Mobile Health Clinic, The University of Texas Health Science Center at Houston, USA.

C Carey (C)

Su Clínica, USA.

L Guerra (L)

Su Clínica, USA.

J M Carvajal (JM)

Secretaria de Salud, Hospital General de Matamoros, Mexico.

E Marin (E)

Su Clínica, USA.

E Baker (E)

The University of Texas MD Anderson Cancer Center, USA.

S Fisher-Hoch (S)

UTHealth School of Public Health in Brownsville, The University of Texas Health Science Center at Houston, USA.

A M Rodriguez (AM)

The University of Texas Medical Branch, USA.

N Burkalter (N)

Mercy Ministries of Laredo, USA.

B Cavazos (B)

Su Clínica, USA.

M Gasca (M)

UTHealth School of Public Health in Brownsville, The University of Texas Health Science Center at Houston, USA.

M M Cuellar (MM)

Su Clínica, USA.

E Robles (E)

Gateway Community Health Center, Inc., USA.

E Lopez (E)

Gateway Community Health Center, Inc., USA.

K Schmeler (K)

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH